<?xml version="1.0" encoding="iso-8859-1" ?>
<rss version="2.0" xmlns:s="http://resources.bnet.com/">
<channel>
	<title><![CDATA[EpiCept Corp. | Company News & Executive Profiles - EPCT | BNET]]></title>
	<link><![CDATA[http://resources.bnet.com/topic/epicept+corp..html?i=11]]></link>
	<description><![CDATA[Latest company news & analysis, recent events, stock quotes, earning call transcripts, with profiles and descriptions of top business executives for EpiCept Corp.]]></description>
	<s:counts start="0" returned="10" found="42" />
	<language>en-us</language>
	<item>
		<title><![CDATA[Anadys: Better Speculative Plays Out There]]></title>
		<link><![CDATA[http://dw.com.com/redir?destUrl=http%3A%2F%2Fseekingalpha.com%2Farticle%2F160784-anadys-better-speculative-plays-out-there%3Fsource%3Dbnet&siteid=23&tag=seekingalpha]]></link>
		<description><![CDATA[VFC submits:  In response to a number of requests that I've received via email or comments asking for 'VFC's Take' on numerous stocks that readers have found, I'll do my best to address as many as I can, as long as everyone takes a few things into account while...]]></description>
		<s:doctype><![CDATA[External links]]></s:doctype>
		<enclosure url="http://i.bnet.com/images/200803/icon_seekingalpha.gif" type="image/gif" />
		<pubDate>Thu, 10 Sep 2009 02:32:03 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/biotech.html"><![CDATA[Biotech]]></category>
		<category domain="http://resources.bnet.com/topic/vfc%2527s+stock+house.html"><![CDATA[VFC's Stock House]]></category>
		<category domain="http://resources.bnet.com/topic/anadys+pharmaceuticals+inc..html"><![CDATA[Anadys Pharmaceuticals Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/epicept+corp..html"><![CDATA[EpiCept Corp.]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">ANDS</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">EPCT</category>
		<category domain="tickers">ANDS,EPCT</category>
	</item>
	<item>
		<title><![CDATA[Epicept Investors Still Waiting on News of a Partner]]></title>
		<link><![CDATA[http://dw.com.com/redir?destUrl=http%3A%2F%2Fseekingalpha.com%2Farticle%2F160212-epicept-investors-still-waiting-on-news-of-a-partner%3Fsource%3Dbnet&siteid=23&tag=seekingalpha]]></link>
		<description><![CDATA[VFC submits:  Shares of Epicept EPCT have logged quite the volatile week of trading after a price spike carried shares to near the $1 mark before immediately retreating to the eighty cent level.A press release was issued on Thursday by the company highlighting some recent positive recognition for Ceplene,...]]></description>
		<s:doctype><![CDATA[External links]]></s:doctype>
		<enclosure url="http://i.bnet.com/images/200803/icon_seekingalpha.gif" type="image/gif" />
		<pubDate>Sun, 06 Sep 2009 06:48:38 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/biotech.html"><![CDATA[Biotech]]></category>
		<category domain="http://resources.bnet.com/topic/vfc%2527s+stock+house.html"><![CDATA[VFC's Stock House]]></category>
		<category domain="http://resources.bnet.com/topic/epicept+corp..html"><![CDATA[EpiCept Corp.]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">EPCT</category>
		<category domain="tickers">EPCT</category>
	</item>
	<item>
		<title><![CDATA[EpiCept Is on the Move]]></title>
		<link><![CDATA[http://dw.com.com/redir?destUrl=http%3A%2F%2Fseekingalpha.com%2Farticle%2F159980-epicept-is-on-the-move%3Fsource%3Dbnet&siteid=23&tag=seekingalpha]]></link>
		<description><![CDATA[Shares of EpiCept (NASDAQ: EPCT) are on the move as speculation about coming news had shares trading up more than 21% on Wednesday and even higher overnight in Europe where shares for the company are also traded on the NASDAQ OMX Nordic Exchange on Thursday morning. The Company possesses an...]]></description>
		<s:doctype><![CDATA[External links]]></s:doctype>
		<enclosure url="http://i.bnet.com/images/200803/icon_seekingalpha.gif" type="image/gif" />
		<pubDate>Fri, 04 Sep 2009 02:57:07 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/healthcare.html"><![CDATA[Healthcare]]></category>
		<category domain="http://resources.bnet.com/topic/m.+e.+garza.html"><![CDATA[M. E. Garza]]></category>
		<category domain="http://resources.bnet.com/topic/epicept+corp..html"><![CDATA[EpiCept Corp.]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">EPCT</category>
		<category domain="tickers">EPCT</category>
	</item>
	<item>
		<title><![CDATA[EpiCept Trading on High Volume]]></title>
		<link><![CDATA[http://dw.com.com/redir?destUrl=http%3A%2F%2Fseekingalpha.com%2Farticle%2F141513-epicept-trading-on-high-volume%3Fsource%3Dbnet&siteid=23&tag=seekingalpha]]></link>
		<description><![CDATA[VFC submits:  Three days ago I wrote that Epicept EPCT was a stock worth watching as the company signed a partner to distribute Ceplene in a world wide named patient program.The news that Ceplene, Epicept's drug that is intended to prevent leukemia relapse in patients with Acute Myeloid Leukemia...]]></description>
		<s:doctype><![CDATA[External links]]></s:doctype>
		<enclosure url="http://i.bnet.com/images/200803/icon_seekingalpha.gif" type="image/gif" />
		<pubDate>Fri, 05 Jun 2009 01:26:27 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/biotech.html"><![CDATA[Biotech]]></category>
		<category domain="http://resources.bnet.com/topic/healthcare.html"><![CDATA[Healthcare]]></category>
		<category domain="http://resources.bnet.com/topic/vfc%2527s+stock+house.html"><![CDATA[VFC's Stock House]]></category>
		<category domain="http://resources.bnet.com/topic/epicept+corp..html"><![CDATA[EpiCept Corp.]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">EPCT</category>
		<category domain="tickers">EPCT</category>
	</item>
	<item>
		<title><![CDATA[Epicept Still Searching for Partner to Help Launch Its Latest Drug]]></title>
		<link><![CDATA[http://dw.com.com/redir?destUrl=http%3A%2F%2Fseekingalpha.com%2Farticle%2F141069-epicept-still-searching-for-partner-to-help-launch-its-latest-drug%3Fsource%3Dbnet&siteid=23&tag=seekingalpha]]></link>
		<description><![CDATA[VFC submits:  Epicept Corporation EPCT announced on Tuesday that a partner has been found for Ceplene, the company's drug that is approved in the European Union for maintenance therapy for adult patients with AML in first remission. However, the partnership agreement is not in preparation for the commercial launch...]]></description>
		<s:doctype><![CDATA[External links]]></s:doctype>
		<enclosure url="http://i.bnet.com/images/200803/icon_seekingalpha.gif" type="image/gif" />
		<pubDate>Wed, 03 Jun 2009 03:50:08 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/biotech.html"><![CDATA[Biotech]]></category>
		<category domain="http://resources.bnet.com/topic/healthcare.html"><![CDATA[Healthcare]]></category>
		<category domain="http://resources.bnet.com/topic/vfc%2527s+stock+house.html"><![CDATA[VFC's Stock House]]></category>
		<category domain="http://resources.bnet.com/topic/epicept+corp..html"><![CDATA[EpiCept Corp.]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">EPCT</category>
		<category domain="tickers">EPCT</category>
	</item>
	<item>
		<title><![CDATA[Epicept: How Long Will Investors Wait?]]></title>
		<link><![CDATA[http://dw.com.com/redir?destUrl=http%3A%2F%2Fseekingalpha.com%2Farticle%2F140294-epicept-how-long-will-investors-wait%3Fsource%3Dbnet&siteid=23&tag=seekingalpha]]></link>
		<description><![CDATA[VFC submits:  Shares of Epiecept EPCT rose nearly 15% in early trading on Thursday after the company released news regarding its early stage anti-tumor agent Crinobulin. The full results of an already completed Phase I trial will be presented at the annual American Society of Clinical Oncology ASCO meeting...]]></description>
		<s:doctype><![CDATA[External links]]></s:doctype>
		<enclosure url="http://i.bnet.com/images/200803/icon_seekingalpha.gif" type="image/gif" />
		<pubDate>Fri, 29 May 2009 07:40:35 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/biotech.html"><![CDATA[Biotech]]></category>
		<category domain="http://resources.bnet.com/topic/vfc%2527s+stock+house.html"><![CDATA[VFC's Stock House]]></category>
		<category domain="http://resources.bnet.com/topic/epicept+corp..html"><![CDATA[EpiCept Corp.]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">EPCT</category>
		<category domain="tickers">EPCT</category>
	</item>
	<item>
		<title><![CDATA[Epicept May Have Potential, But How Long are Investors Willing to Wait?]]></title>
		<link><![CDATA[http://dw.com.com/redir?destUrl=http%3A%2F%2Fseekingalpha.com%2Farticle%2F139127-epicept-may-have-potential-but-how-long-are-investors-willing-to-wait%3Fsource%3Dbnet&siteid=23&tag=seekingalpha]]></link>
		<description><![CDATA[VFC submits:  When the European Commission decided to approve Ceplene last October, Epicept EPCT looked to be as safe an investment as any since the only thing that stood in the way of Epicept and a revenue stream was the search for a marketing partner. Now, seven months later,...]]></description>
		<s:doctype><![CDATA[External links]]></s:doctype>
		<enclosure url="http://i.bnet.com/images/200803/icon_seekingalpha.gif" type="image/gif" />
		<pubDate>Fri, 22 May 2009 12:56:12 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/biotech.html"><![CDATA[Biotech]]></category>
		<category domain="http://resources.bnet.com/topic/healthcare.html"><![CDATA[Healthcare]]></category>
		<category domain="http://resources.bnet.com/topic/vfc%2527s+stock+house.html"><![CDATA[VFC's Stock House]]></category>
		<category domain="http://resources.bnet.com/topic/epicept+corp..html"><![CDATA[EpiCept Corp.]]></category>
		<category domain="http://resources.bnet.com/topic/myriad+genetics+inc..html"><![CDATA[Myriad Genetics Inc.]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">EPCT</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">MYGN</category>
		<category domain="tickers">EPCT,MYGN</category>
	</item>
	<item>
		<title><![CDATA[EpiCept Regains Compliance with Nasdaq Listing Rule]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_m0EIN/is_2008_August_28/ai_n28043352]]></link>
		<description><![CDATA[TARRYTOWN, N.Y. -- Regulatory News:  EpiCept Corporation (Nasdaq and OMX Nordic Exchange: EPCT) today announced that it has been deemed in compliance with the Nasdaq Hearings Panel's decision dated August 6, 2008 and that accordingly, the Panel has determined to continue the listing of EpiCept's securities on The Nasdaq...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Thu, 28 Aug 2008 23:59:59 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/company.html"><![CDATA[Company]]></category>
		<category domain="http://resources.bnet.com/topic/epicept+corp..html"><![CDATA[EpiCept Corp.]]></category>
		<category domain="http://resources.bnet.com/topic/healthcare.html"><![CDATA[HEALTHCARE]]></category>
		<category domain="http://resources.bnet.com/topic/nasdaq+stock+market+inc..html"><![CDATA[Nasdaq Stock Market Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">EPCT</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">NDAQ</category>
		<category domain="tickers">EPCT,NDAQ</category>
	</item>
	<item>
		<title><![CDATA[EpiCept Corporation Q4 2007 Earnings Call Transcript]]></title>
		<link><![CDATA[http://www.bnet.com/2462-14055_23-229604.html]]></link>
		<description><![CDATA[ Question-and-Answer SessionOperator Thank you. Operator Instructions. There are no questions at this time. Jack Talley Okay. Well thank you for your participation in this mornings call. We believe we will have the opportunity this year to realize the promise from our diversified portfolio of valuable cancer and pain management...]]></description>
		<s:doctype><![CDATA[Earnings calls]]></s:doctype>
		<enclosure url="http://i.bnet.com/images/200803/icon_seekingalpha.gif" type="image/gif" />
		<pubDate>Fri, 29 Feb 2008 08:17:07 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://resources.bnet.com/topic/epicept+corp..html"><![CDATA[EpiCept Corp.]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">EPCT</category>
		<category domain="tickers">EPCT</category>
	</item>
	<item>
		<title><![CDATA[EpiCept Corporation Announces New Research Demonstrates Broad Efficacy of Azixa(TM) (MPC-6827) Against Multiple Tumor Types and in Drug Resistant Cell Lines.]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_hb5243/is_200706/ai_n19760324]]></link>
		<description><![CDATA[M2 PRESSWIRE-15 June 2007-Headline Maker: EpiCept Corporation  Announces New Research Demonstrates Broad Efficacy of AzixaTM  (MPC-6827) Against Multiple Tumor Types and in Drug Resistant Cell  LinesC1994-2007 M2 COMMUNICATIONS LTD    RDATE:15062007    Market Gainer is quickly emerging as the one stop shop for...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Fri, 15 Jun 2007 23:59:59 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/cell.html"><![CDATA[cell]]></category>
		<category domain="http://resources.bnet.com/topic/compound.html"><![CDATA[compound]]></category>
		<category domain="http://resources.bnet.com/topic/efficacy.html"><![CDATA[efficacy]]></category>
		<category domain="http://resources.bnet.com/topic/epicept+corp..html"><![CDATA[EpiCept Corp.]]></category>
		<category domain="http://resources.bnet.com/topic/investor.html"><![CDATA[investor]]></category>
		<category domain="http://resources.bnet.com/topic/nasdaq+stock+market+inc..html"><![CDATA[Nasdaq Stock Market Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/researcher.html"><![CDATA[researcher]]></category>
		<category domain="http://resources.bnet.com/topic/security.html"><![CDATA[security]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">EPCT</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">NDAQ</category>
		<category domain="tickers">EPCT,NDAQ</category>
	</item>
</channel>
</rss>
